Brand Asset Management Group’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Brand Asset Management Group’s Portfolio PBLA Stock Details PBLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2	Closed	-$15K	–	77
2022 Q3	$15K	Hold	2	–	–	0.01%	75
2022 Q2	$38K	Hold	2	–	–	0.02%	77
2022 Q1	$121K	Hold	2	–	–	0.05%	81
2021 Q4	$99K	Hold	2	–	–	0.04%	77
2021 Q3	$124K	Hold	2	–	–	0.06%	76
2021 Q2	$162K	Hold	2	–	–	0.08%	76
2021 Q1	$226K	Hold	2	–	–	0.12%	68
2020 Q4	$203K	Buy	+2	New	+$160K	0.11%	68

Other funds holding PBLA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFG

Oxford Financial Group Carmel, Indiana $1.86B AUM 19.25% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Brand Asset Management Group's PBLA Position: Q4 2022 in Review

Brand Asset Management Group sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q4 2022, closing a stake of 2 shares — an estimated $15K sold.

Brand Asset Management Group first reported a position in PBLA in Q4 2020 and held it in 8 quarters. The position peaked at $226K in Q1 2021. 10 funds tracked by Wall St. Rank hold PBLA as of Q4 2022.

Brand Asset Management Group reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Brand Asset Management Group sold 2 Panbela Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $15K.
Brand Asset Management Group first reported a position in Panbela Therapeutics, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Brand Asset Management Group's Panbela Therapeutics, Inc. Common Stock position peaked at $226K in Q1 2021.
10 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Brand Asset Management Group's 13F filing for Q4 2022, filed 24 Jan 2023.